Bill & Melinda Gates Foundation
Overview
Grant-making foundation supporting education and global health initiatives.
Founded
1997
Deals ยท 12mo
16
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
ProFound Therapeutics | Aug 2026Led | $20 MOther Equity | |
Nbryo | Aug 2026Participated | $20 MSeed | |
Leyden Labs | Jun 2026Participated | $45 MOther Equity | |
Converge Bio | Jun 2026Led | $3 MGrant | |
Kanvas Biosciences | May 2026Participated | $48 MSeries A | |
Rainbow Crops | Mar 2026Led | $7 MGrant | |
PlasmaLeap | Mar 2026Led | $21 MSeries A | |
Ten63 Therapeutics | Feb 2026Led | $45 MOther Equity | |
Axmed | Feb 2026Led | $6 MGrant | |
Heritable Agriculture | Jan 2026Led | $5 MGrant | |
Addition Therapeutics | Dec 2025Participated | $100 MOther Equity | |
Chemify | Dec 2025Led | $2 MGrant | |
ProFound Therapeutics | Aug 2026Led | $20 MOther Equity | |
Nbryo | Aug 2026Participated | $20 MSeed | |
Leyden Labs | Jun 2026Participated | $45 MOther Equity | |
Converge Bio | Jun 2026Led | $3 MGrant | |
Kanvas Biosciences | May 2026Participated | $48 MSeries A | |
Rainbow Crops | Mar 2026Led | $7 MGrant | |
PlasmaLeap | Mar 2026Led | $21 MSeries A | |
Ten63 Therapeutics | Feb 2026Led | $45 MOther Equity | |
Axmed | Feb 2026Led | $6 MGrant | |
Heritable Agriculture | Jan 2026Led | $5 MGrant | |
Addition Therapeutics | Dec 2025Participated | $100 MOther Equity | |
Chemify | Dec 2025Led | $2 MGrant |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 2 | 4 |
| Series A | 7 | 12 |
| Series B | 3 | 11 |
| Series C+ | 2 | 9 |
| Other Equity | 21 | 11 |
| Grant | 43 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Feb '11 | 1 |
| Mar '11 | 1 |
| Apr '11 | 0 |
| May '11 | 0 |
| Jun '11 | 0 |
| Jul '11 | 0 |
| Aug '11 | 0 |
| Sep '11 | 0 |
| Oct '11 | 0 |
| Nov '11 | 0 |
| Dec '11 | 1 |
| Jan '12 | 0 |
| Feb '12 | 0 |
| Mar '12 | 0 |
| Apr '12 | 0 |
| May '12 | 0 |
| Jun '12 | 0 |
| Jul '12 | 0 |
| Aug '12 | 0 |
| Sep '12 | 1 |
| Oct '12 | 2 |
| Nov '12 | 2 |
| Dec '12 | 0 |
| Jan '13 | 0 |
| Feb '13 | 0 |
| Mar '13 | 0 |
| Apr '13 | 0 |
| May '13 | 0 |
| Jun '13 | 0 |
| Jul '13 | 0 |
| Aug '13 | 0 |
| Sep '13 | 0 |
| Oct '13 | 0 |
| Nov '13 | 0 |
| Dec '13 | 2 |
| Jan '14 | 0 |
| Feb '14 | 0 |
| Mar '14 | 0 |
| Apr '14 | 1 |
| May '14 | 1 |
| Jun '14 | 1 |
| Jul '14 | 0 |
| Aug '14 | 0 |
| Sep '14 | 0 |
| Oct '14 | 2 |
| Nov '14 | 0 |
| Dec '14 | 0 |
| Jan '15 | 0 |
| Feb '15 | 0 |
| Mar '15 | 0 |
| Apr '15 | 0 |
| May '15 | 0 |
| Jun '15 | 2 |
| Jul '15 | 1 |
| Aug '15 | 1 |
| Sep '15 | 0 |
| Oct '15 | 0 |
| Nov '15 | 2 |
| Dec '15 | 0 |
| Jan '16 | 1 |
| Feb '16 | 1 |
| Mar '16 | 0 |
| Apr '16 | 0 |
| May '16 | 0 |
| Jun '16 | 0 |
| Jul '16 | 1 |
| Aug '16 | 0 |
| Sep '16 | 0 |
| Oct '16 | 1 |
| Nov '16 | 1 |
| Dec '16 | 2 |
| Jan '17 | 2 |
| Feb '17 | 0 |
| Mar '17 | 1 |
| Apr '17 | 1 |
| May '17 | 0 |
| Jun '17 | 0 |
| Jul '17 | 0 |
| Aug '17 | 0 |
| Sep '17 | 1 |
| Oct '17 | 1 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 1 |
| Jun '18 | 2 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 1 |
| Oct '18 | 0 |
| Nov '18 | 1 |
| Dec '18 | 1 |
| Jan '19 | 1 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 1 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 1 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 2 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 2 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 1 |
| Jul '20 | 1 |
| Aug '20 | 1 |
| Sep '20 | 0 |
| Oct '20 | 2 |
| Nov '20 | 0 |
| Dec '20 | 1 |
| Jan '21 | 2 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 1 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 1 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 1 |
| Nov '21 | 1 |
| Dec '21 | 1 |
| Jan '22 | 1 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 1 |
| May '22 | 3 |
| Jun '22 | 1 |
| Jul '22 | 1 |
| Aug '22 | 3 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 3 |
| Dec '22 | 1 |
| Jan '23 | 1 |
| Feb '23 | 0 |
| Mar '23 | 1 |
| Apr '23 | 1 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 1 |
| Aug '23 | 2 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 4 |
| Dec '23 | 4 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 1 |
| Apr '24 | 3 |
| May '24 | 1 |
| Jun '24 | 1 |
| Jul '24 | 3 |
| Aug '24 | 0 |
| Sep '24 | 1 |
| Oct '24 | 1 |
| Nov '24 | 1 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 2 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 1 |
| Jul '25 | 0 |
| Aug '25 | 1 |
| Sep '25 | 1 |
| Oct '25 | 3 |
| Nov '25 | 3 |
| Dec '25 | 2 |
| Jan '26 | 1 |
| Feb '26 | 2 |
| Mar '26 | 2 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 2 |
| Jul '26 | 0 |
| Aug '26 | 2 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 99 |
| Food & Agriculture | 16 |
| Networks, Cloud & Communication | 13 |
| AI & Machine Learning | 13 |
| Space & Frontier Tech | 12 |
| Data, Analytics & IT | 9 |
| Enterprise Software | 8 |
| Education & Workforce | 7 |
| Hardware & Robotics | 7 |
| Fintech | 7 |
| Professional Services | 7 |
| Manufacturing | 5 |
| Consumer & Lifestyle | 4 |
| Government & Defense | 3 |
| Social & Community Platforms | 3 |
| E-Commerce & Retail | 2 |
| Clean Energy & Sustainability | 2 |
| Developer Tools | 2 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 42 |
| $5M-$10M | 25 |
| $10M-$25M | 25 |
| $25M-$50M | 19 |
| $50M-$100M | 8 |
| $100M-$250M | 6 |
| $250M-$500M | 1 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 10 of 10 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 74 |
| Europe | 28 |
| India | 7 |
| Canada | 5 |
| Australia | 5 |
| Kenya | 2 |
| Nigeria | 2 |
| Israel | 1 |
| Bangladesh | 1 |
| Singapore | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Alexandria Venture Investments | 7 |
| Polaris Partners | 7 |
| ARCH Venture Partners | 4 |
| Johnson & Johnson Innovation | 4 |
| Lux Capital | 4 |
| Eli Lilly and Company | 3 |
| Germin8 Ventures | 3 |
| Omega Funds | 3 |
| 5AM Ventures | 2 |
| Alumni Ventures | 2 |
| Anterra Capital | 2 |
| Birchmere Ventures | 2 |
| Blume Ventures | 2 |
| Catalio Capital Management | 2 |
| Cormorant Asset Management | 2 |
| Cycad Group | 2 |
| F-Prime Capital | 2 |
| Finistere Ventures | 2 |
| Flagship Pioneering | 2 |
| Flagship Ventures | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 78 | 62% |
| Participating | 48 | 38% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 66 | 85% |
| Co-led | 12 | 15% |
Team
Director of the Water, Sanitation & Hygiene Program
Director, Pacific Northwest
Sr. Advisor, Global Education
Director, Women's Economic Empowerment
Co-chair and Trustee
Co-Principal Investigator
Director, Global Development
Trustee